What are the primary supply chain bottlenecks and operational risk factors for Akebia Therapeutics, Inc. (AKBA)?
What are the primary supply chain bottlenecks and operational risk factors for Akebia Therapeutics, Inc. (AKBA)?
Operational risk modeling and supply chain dependency mapping for Akebia Therapeutics, Inc. (ticker AKBA) examines component procurement timelines, geographic manufacturing exposure, and key supplier concentration. Within the BIOTECH_FDA ecosystem, geopolitical supply constraints, export control restrictions, and logistical lead times directly influence inventory turns and gross margin defensibility. Quantitative analysts continuously calibrate operational resilience metrics to gauge vulnerability against macro supply chain disruptions.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Is Cross | false |
| Has Whale | true |
| Has Congress | false |
| Has Contract | false |
| Darkpool Ratio | 0.7421 |
Full trading intelligence, federal contract history and congressional flow for AKBA.
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.